ALEXART: Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder

Sponsor

University Hospital, Angers (Other)

Overall Status

Recruiting

CT.gov ID

NCT04206930

Collaborator

(none)

128

Enrollment

Location

Arms

Anticipated Duration (Months)

3.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Art therapy support combined with standard care for people with an alcohol use disorder coming to a day hospital for withdrawal could be beneficial compared to standard care alone because it would improve the alexithymia of these patients, helping them to better identify their feelings and / or emotions, and improve their self-confidence, their self-esteem self and their oral communication.

Condition or Disease	Intervention/Treatment	Phase
Alexithymia Alcohol Use Disorder	Other: Art Therapy	N/A

Detailed Description

Alexithymia is an inability to identify and describe one's emotions associated with outward thinking. Frequently found in people with an alcohol use disorder, a true mental handicap, alexithymia has been clearly identified as a relapse factor in addictive problems related to alcohol. The ALEXART study intends to study the evolution of alexithymia in people with an alcohol use disorder hosted in an Addictology Day Hospital unit through the use of an approach non-drug that is art therapy. Our hypothesis is that art therapy can help patients with alcohol use disorders to develop a better understanding of their own behaviors, to name their emotions and feelings, and to improve their communication with others and thereby be able to choose to change their behavior.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

128 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder

Actual Study Start Date :

Dec 13, 2019

Anticipated Primary Completion Date :

Jan 7, 2020

Anticipated Study Completion Date :

Dec 13, 2022

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: Control Standard support: information on alcoholic pathology, medico-psycho-social assessment, relapse prevention program
Experimental: Art-Therapy in addition to standard treatment, art therapy treatment program: 1 session of 2 hours per week in a closed group for 10 weeks	Other: Art Therapy 1 session of 2 hours per week in a closed group for 10 weeks

Arm

Intervention/Treatment

No Intervention: Control

Standard support: information on alcoholic pathology, medico-psycho-social assessment, relapse prevention program

Experimental: Art-Therapy

in addition to standard treatment, art therapy treatment program: 1 session of 2 hours per week in a closed group for 10 weeks

Other: Art Therapy

1 session of 2 hours per week in a closed group for 10 weeks

Outcome Measures

Primary Outcome Measures

Echelle de Toronto (TAS) [3 month after inclusion]
self-questionnaire which includes 20 items and allows to measure 3 factors: Difficulty identifying feelings (TAS 1). Difficulty expressing feelings (TAS 2). Outward-oriented thinking (TAS 3).

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Adult 18 or over
Patient with an alcohol use disorder starting day hospital care in the psychiatry and addiction department of the Angers University Hospital
Subjects who gave and signed informed consent to participate in the study with alexithymia (Toronto Test greater than or equal to 56)

Exclusion Criteria:

Non-understanding of the French language
Non-affiliation to a social security scheme
Major cognitive impairment
Motor problems preventing walking
Protective patients
Pregnant or lactating women
Patients under protection of justice or deprived of liberty
Patients under protective supervision or guardianship

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Centre Hospitalier Universitaire	Angers		France	49033

Sponsors and Collaborators

University Hospital, Angers

Investigators

Study Director: BENEDICTE GOHIER, CHU ANGERS SERVICE DE PSYCHIATRIE ADDICTOLOGIE

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University Hospital, Angers

ClinicalTrials.gov Identifier:

NCT04206930

Other Study ID Numbers:

2017-A02031-52

First Posted:

Dec 20, 2019

Last Update Posted:

Dec 20, 2019

Last Verified:

Dec 1, 2019

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Alcoholism

Alcohol Drinking

Affective Symptoms

Study Results

No Results Posted as of Dec 20, 2019